News & Views

Read the latest RCOphth news updates and guidance here.

News

Abusive Head Trauma and the Eye – Membership Consultation

The Royal College of Ophthalmologists have, through a guideline development group (GDG) chaired by Mr Patrick Watts, produced a clinical guideline on Abusive Head Trauma and the Eye. A draft version of this guideline has now been released for consultation and the College would welcome any comments or observations on the content, format or recommendations.

News

Work to identify capacity challenges and explore solutions in paediatric ophthalmology enters next stage

In November 2022, The Royal College of Ophthalmologists Paediatric Sub-committee held a series of focus groups to explore the challenges facing paediatric eye care and identify possible solutions to secure the future of the workforce. Following the conclusion of these focus groups, the RCOphth has produced ‘Improving the visibility of paediatric ophthalmology: A workforce report‘ detailing key findings

News

RCOphth Congress 2024 - Congress session proposal

The 2024 Congress will take place at the ICC, Belfast from 20 – 23  May 2024 and will be fully in person, with talks available on demand after the meeting. The College are looking for suggestions for parallel sessions. These can be 60 or 90 minutes and can cover any aspect of ophthalmology. We are particularly looking for sessions that cover the latest research, innovations or treatments and have something new to say. Topics can cover any aspect of ophthalmology, whether a broad overview of a subspecialty or a narrower focus on a particular disease.

News

Clinical Audit Awareness Week

This week (19 – 23 June) is Clinical Audit Awareness Week, a national annual campaign that promotes and celebrates the impact of clinical audits in healthcare. RCOphth runs the world renowned National Ophthalmology Database Audit and is recognised by clinicians, NICE, GIRFT and industry as an important safety and research tool that is used to audit the treatment of cataracts and recently has added the potentially blinding disease of age-related macular degeneration (AMD) to its work.